Anlotinib: Clinical Trials

2 trials for Anlotinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Unknown 1
Phase 21Unknown 1

Follow Anlotinib: new trials by email Literature Review of Anlotinib trials Research Report on Anlotinib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer
Anlotinib plus AK105 - Anlotinib, Anti-PD-1 Antibody
Phase 1 / Phase 2UnknownPeking Union Medical College Hospital292021-05-122023-06-22
Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer
Anlotinib Hydrochloride - Non-squamous Non-small-cell Lung Cancer, Anlotinib
Phase 1CompletedSichuan University82019-04-302023-08-03

Interventions

Pemetrexed (1)  ·  anlotinib (1)

Sponsors

Peking Union Medical College Hospital (1)  ·  Sichuan University (1)

Countries

China (2)

Top investigators

You Lu, MD (1)